Technology Networks spoke to the most productive researcher in spatial transcriptomics, Professor Joakim Lundeberg, about the ...

As part of the agreement, Parse admitted that 10x Genomics' ATAC-seq patents are valid, enforceable, and had been infringed by Parse's use of ATAC-seq methods and compositions. Meanwhile ...

March 3, 2025 /PRNewswire/ — 10x Genomics (Nasdaq ... enforceable and infringed by Parse’s use of ATAC-seq methods and compositions. “This development further validates the strength of ...

10x Genomics and Syncell streamline cutting-edge ... a much less invasive blood test has demonstrated comparable accuracy to these methods. ALZpath has developed a proprietary antibody that ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments ...

comes as a result of Parse Biosciences admitting that 10x Genomics’ patents related to ATAC-seq methods and compositions are valid, enforceable, and were infringed upon by their activities.

Two recent UPC decisions have provided some guidance on the admissibility and reasonableness of auxiliary requests in revocation actions. The ...

This comes on the heels of Parse invalidating the patents that 10x Genomics had asserted against ... novel approach with advantages over existing methods such as ATAC-seq and will deliver higher ...

The authors have generated important resources such as a reference dataset of early primate development by utilizing single-cell transcriptomic technology together with induced pluripotent stem cells ...

March 3, 2025 /PRNewswire/ — 10x Genomics (Nasdaq: TXG), a leader in single-cell and ... enforceable and infringed by Parse’s use of ATAC-seq methods and compositions. “This development further ...